Concepedia

Publication | Closed Access

132 EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE

12

Citations

0

References

2021

Year

No additional data available for this publication yet. Check back later!